What is the current price and intraday move for 2228.HK stock?

As of this intraday update on 05 Feb 2026, 2228.HK stock trades at **HK$11.38**, down **2.40%**, with a day range of **HK$11.11–HK$11.58** and volume **48,589,589.00** shares.

What valuation metrics matter for 2228.HK stock?

Key metrics include **PE 10.94**, **EPS HK$1.04**, price-to-sales **63.88**, and price-to-book **5.44**. These show a premium market valuation versus Hong Kong healthcare peers and highlight execution and cash-flow risk.

What is Meyka AI's forecast for 2228.HK stock?

Meyka AI's forecast model projects a **monthly target HK$14.10** and a quarterly target **HK$13.43**, implying a near-term upside of about **23.90%** from **HK$11.38**. Forecasts are model-based projections and not guarantees.

When is the next earnings date for 2228.HK stock?

XtalPi's next earnings announcement is scheduled for **2026-03-27**. Investors should watch revenue guidance, R&D spend and cash flow updates ahead of that report.

HK Stocks

2228.HK XtalPi (HKSE) down 2.40% intraday 05 Feb 2026: 23.90% model upside

ByHuzaifa Zahoor February 5, 2026

The 2228.HK stock opened lower and trades at HK$11.38, down 2.40% intraday on 05 Feb 2026 on the HKSE in Hong Kong. Volume is elevated at 48,589,589.00 shares against a 50-day average of 76,674,218.00, signalling active trading in this AI drug-discovery name. XtalPi Holdings Ltd (2228.HK) mixes AI platforms and lab automation across China, the US and Japan and faces near-term news flow ahead of earnings on 2026-03-27. We review valuation, technicals, Meyka AI forecasts, and the key catalysts for AI-sector investors focused on 2228.HK stock.